Fluoroquinolone resistance in salmonella enterica serotype choleraesuis, Taiwan, 2000-2003

Emerging Infectious Diseases

Volumn 10, Issue 9, 2004, Pages 1674-1676

  Chiu, Cheng Hsun ^a   Wu, Tsu Lan ^b   Su, Lin Hui ^b   Liu, Jien Wei ^b   Chu, Chishih ^a  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; DNA FINGERPRINTING; FOOD CONTAMINATION; GEOGRAPHIC ORIGIN; HOSPITAL; HUMAN; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROTYPE CHOLERAESUIS; SALMONELLOSIS; SEROTYPE; SWINE; TAIWAN;

EID: 4444252493     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1009.030596     Document Type: Article

References (10)

1. Su LH, Chiu CH, Kuo AJ, Chia JH, Sun CF, Leu HS, et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect. 2001;127:207-13.
2. Chiu CH, Wu TL, Su LH, Chu C, Chia JH, Kuo AJ, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med. 2002;346:413-9.
3. Farmer JJ III. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 6th ed. Washington: American Society for Microbiology; 1995. p. 438-49.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests for bacteria that grow aerobically. Approved standard M2-A7. 7th ed. Villanova (PA): The Committee; 2000.
5. Centers for Disease Control and Prevention. Salmonella surveillance: annual summary, 2000. Atlanta: U.S. Department of Health and Human Services, Public Health Service; 2000.
6. Chen YH, Peng CF, Tsai JJ, Hwang KP, Lu PL, Cheng HH, et al. Epidemiological study of human salmonellosis during 1991-1996 in southern Taiwan. Kaohsiung J Med Sci. 1999;15:127-36.
7. Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infections of non-typhoidal Salmonella in patients without AIDS. Int J Clin Pract. 1999;53:161-4.
8. Chiu CH, Su LH, Chu C, Chia JH, Wu TL, Lin TY, et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet. 2004;363:1285-6.
9. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, Yan JJ, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis. 2004;10:60-8.
10. Chu C, Chiu CH, Wu WY, Chu CH, Liu TP, Ou JT. Large drug resistance virulence plasmids of clinical isolate of Salmonella enterica serovar Choleraesuis. Antimicrob Agents Chemother. 2001;45: 2299-303.